What do you know about Thyroid-stimulating hormone? ,
(also known as TSH or thyrotropin ) :
Thyroid-stimulating
hormone is a hormone that stimulates the thyroid gland to produce thyroxine
(T4), and then triiodothyronine (T3) which stimulates the metabolism of almost
every tissue in the body.
TSH stimulates the
thyroid gland to secrete the hormones thyroxine (T4), which has only a slight
effect on metabolism. T4 is converted to triiodothyronine (T3), which is the
active hormone that stimulates metabolism. About 80% of this conversion is in
the liver and other organs, and 20% in the thyroid itself .
In adults, a standard
reference range is between 0.4 and 3.0 µIU/mL (equivalent to mIU/L), but values
vary slightly among labs. In the UK, guidelines issued by the Association for
Clinical Biochemistry suggest a reference range of 0.4-4.5 mIU/L.
The National Academy
of Clinical Biochemistry (NACB) stated that it expected the normal range for
adults to be reduced to 0.4–2.5 µIU/mL, because research had shown that adults
with an initially measured TSH level of over 2.0 µIU/mL had "an increased odds
ratio of developing hypothyroidism over the [following] 20 years, especially if
thyroid antibodies were elevated"
TSH concentrations in
children are normally higher than in adults. In 2002, the NACB recommended
age-related reference limits starting from about 1.3 to 19 µIU/mL for
normal-term infants at birth, dropping to 0.6–10 µIU/mL at 10 weeks old,
0.4–7.0 µIU/mL at 14 months and gradually dropping during childhood and puberty
to adult levels, 0.4–4.0 µIU/mL
Diagnosis of
disease :
TSH concentrations are
measured as part of a thyroid function test in patients suspected of having
an
excess (hyperthyroidism) or deficiency (hypothyroidism) of thyroid hormones.
Interpretation of the results depends on both the TSH and T4 concentrations. In
some situations measurement of T3 may also be useful.
Monitoring
The therapeutic
target range TSH.. level for patients on treatment ranges between 0.3 to 3.0
μIU/mL .
For hypothyroid
patients on thyroxine, measurement of TSH alone is generally considered
sufficient. An increase in TSH above the normal range indicates
under-replacement or poor compliance with therapy.
A significant
reduction in TSH suggests over-treatment. In both cases, a change in dose may
be required.
For hyperthyroid
patients, both TSH and T4 are usually monitored.
Therapeutic :
A synthetic drug
called recombinant human TSH alpha (rhTSHα or simply rhTSH, (trade name
Thyrogen), is manufactured by Genzyme Corp..
The rhTSH is used to
treat thyroid cancer.
No comments:
Post a Comment